The 2020 Advanced Learning in Palliative Medicine Conference will be held in Hamilton, Ontario.
Pre-conference workshop(s): Wednesday, May 27, 2020
Regular conference program: Thursday, May 28 through Saturday, May 30, 2020
The Conference Committee is working on the program, using input from conference evaluations and guidance and from Hamilton representatives. The Committee will announce the keynote speakers and invited workshop presenters in the fall.
There will be many opportunities for CSPCP members to contribute to the program including:
- A call to CSPCP members to submit proposals for interactive workshops
- A call for abstracts for poster presentations. Authors of top-scoring abstracts will be invited to give short oral presentations
- A call to Residents for presentations and/or posters regarding their scholarly projects
The timing and deadlines for the calls will be announced in the fall.
(May 17, 2019) The Canadian Society of Palliative Care Physicians released an updated document today entitled Key Messages: Palliative Care and Medical Assistance in Dying (MAiD). MAiD became legal in Canada in June 2016 when the Parliament of Canada passed federal legislation allowing eligible Canadian adults to request it. Prior to the legislation, the CSPCP developed Key Messages about Physician Hastened Death which were released in October 2015. The updated Key Messages reaffirm our original position and frame it in the current Canadian context.
(March 4, 2019) Recently-released Model Standards for Pharmacy Compounding for Non-Hazardous Sterile Preparations from the National Association of Pharmacy Regulatory Authorities (NAPRA) stipulate that community pharmacies must use a Before Use Date of twelve hours for pre-filled medication syringes. This significantly affects our ability to provide care for patients with palliative care needs in the home, especially at end of life.
The CSPCP and Canadian Hospice Palliative Care Association jointly wrote to NAPRA on February 19, 2019, requesting an exception to this standard for palliative care. The letter describes the reasons why care is affected and what the impact is for patients, caregivers, and health care providers. Copies of the letter were sent to Health Canada, to their federal/provincial/territorial/palliative care group, and to the heads of the provincial Sections of Palliative Medicine. We are currently awaiting a response and will provide updates when available.
Read the letter